antipyrine and pyrimidinones

antipyrine has been researched along with pyrimidinones in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chenery, RJ; Cox, PJ; Oldham, HG; Rath, LC; Standring, P1
Graber, H; Krepuska, J; Szentmiklósi, P1
Gergely, V; Mészáros, Z; Sebestyén, G; Virág, S1
Hasegawa, T; Ishikawa, M; Kakui, N; Nakajima, H; Ohkuma, K1

Trials

1 trial(s) available for antipyrine and pyrimidinones

ArticleYear
[Clinical evaluation of the analgesic effect of Probon].
    Orvosi hetilap, 1971, Jul-11, Volume: 112, Issue:28

    Topics: Analgesics; Antipyrine; Carboxylic Acids; Clinical Trials as Topic; Codeine; Humans; Methylamines; Pain; Placebos; Pyrimidinones; Sulfates; Sulfonic Acids

1971

Other Studies

3 other study(ies) available for antipyrine and pyrimidinones

ArticleYear
The interaction of temelastine with cytochrome P450 mixed-function oxidase enzymes in vivo and in vitro.
    Biochemical pharmacology, 1989, Jan-01, Volume: 38, Issue:1

    Topics: Animals; Antipyrine; Cytochrome P-450 Enzyme Inhibitors; Female; Half-Life; Histamine H1 Antagonists; Kinetics; Male; Pyrimidinones; Rats; Rats, Inbred Strains

1989
Investigation of the interaction between Probon and indomethacin in rats.
    Journal of applied toxicology : JAT, 1983, Volume: 3, Issue:1

    Topics: Animals; Antipyrine; Drug Interactions; Drug Therapy, Combination; Female; Indomethacin; Male; Peptic Ulcer; Pyrimidinones; Rats; Rats, Inbred Strains

1983
A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 312, Issue:2

    Topics: Animals; Antipyrine; Brain; Brain Ischemia; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Cerebral Infarction; Dose-Response Relationship, Drug; Edaravone; Enzyme Inhibitors; Fluorescent Antibody Technique; Free Radical Scavengers; Glyceraldehyde-3-Phosphate Dehydrogenases; Neuroprotective Agents; Poly(ADP-ribose) Polymerase Inhibitors; Pyrimidinones; Rats; Rats, Wistar; Reactive Oxygen Species; Substrate Specificity; Time Factors

2005